Asston Pharmaceuticals (BOM:544445) Other Current Payables: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544445 Asston Pharmaceuticals Ltd BOM:544445
19 GF Score
Price ₹79.95
! 3 Warning Signs
View Full Analysis

What is Asston Pharmaceuticals Other Current Payables?

Asston Pharmaceuticals BOM:544445 +1.85% 19 Other Current Payables is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:544445 with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

Asston Pharmaceuticals's Other Current Payables for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Asston Pharmaceuticals's quarterly Other Current Payables declined from Mar. 2025 (₹5.1 Mil) to Sep. 2025 (₹0.0 Mil) but then stayed the same from Sep. 2025 (₹0.0 Mil) to Mar. 2026 (₹0.0 Mil).

Asston Pharmaceuticals's annual Other Current Payables increased from Mar. 2024 (₹1.9 Mil) to Mar. 2025 (₹5.1 Mil) but then declined from Mar. 2025 (₹5.1 Mil) to Mar. 2026 (₹0.0 Mil).

Asston Pharmaceuticals Other Current Payables Related Terms

Asston Pharmaceuticals Other Current Payables Historical Data

* Premium members only.

The historical data trend for Asston Pharmaceuticals's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asston Pharmaceuticals Other Current Payables Chart

Asston Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
1.54 1.55 1.93 5.13 0.00

Asston Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Current Payables Get a 7-Day Free Trial 1.93 0.00 5.13 0.00 0.00
BOM:544445
19GF Score
Asston Pharmaceuticals Ltd BOM:544445
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asston Pharmaceuticals Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹0.0 Mil mean?
Asston Pharmaceuticals (BOM:544445) has a Other Current Payables of ₹0.0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Asston Pharmaceuticals and its competitors.
Is Asston Pharmaceuticals' Other Current Payables too high?
Asston Pharmaceuticals' current Other Current Payables is ₹0.0 Mil. Overall, Asston Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Asston Pharmaceuticals' Other Current Payables compare to ZTS?
Asston Pharmaceuticals' Other Current Payables of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Asston Pharmaceuticals and its competitors. Asston Pharmaceuticals's current Other Current Payables is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asston Pharmaceuticals stock overvalued right now?
Asston Pharmaceuticals (BOM:544445) has a current Other Current Payables of ₹0.0 Mil. The current Other Current Payables is ₹0.0 Mil. Asston Pharmaceuticals' overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Asston Pharmaceuticals (BOM:544445), the current Other Current Payables is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asston Pharmaceuticals Business Description

Address Plot No 42A, Sector-11, 4th Floor, Office No. A-431 Balaji Bhavan, CBD Belapur, Navi Mumbai, Thane, MH, IND, 400 614
Asston Pharmaceuticals Ltd manufactures and exports pharmaceutical and nutraceutical products. The company produces a wide range of healthcare items including tablets, capsules, syrups, sachets, ointments, creams, gels, and lotions. It serves markets in West and South Africa, with expansions planned into Asian countries. Asston conducts business through export sales, contract manufacturing and loan license arrangements via merchant exporters, and domestic sales within India. Revenue is generated through the sale of branded and generic pharmaceutical formulations along with nutraceutical products. The business operations are broadly categorized into: Domestic Formulations, Export Formulations, APIs and Intermediates, and Research and Development.
19GF Score

Get the complete analysis for BOM:544445

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹79.95
Price